The Chronic Kidney Disease Market is expanding as the global burden of kidney disorders increases and healthcare systems place greater emphasis on early detection and disease management. The market reached USD 90.47 billion in 2025 and is projected to reach USD 155.94 billion by 2035, growing at a CAGR of 5.6% during 2026–2035.

Rising diabetes and hypertension prevalence remains a major growth driver because these conditions contribute substantially to chronic kidney disease. At the same time, expanded use of kidney-protective therapies and improved screening are encouraging earlier intervention and creating greater demand for diagnostic and treatment solutions.

Treatment products accounted for 69.7% of market revenue in 2025, while diagnosis products are expected to grow at a faster 7.2% CAGR. Hospitals represented 40.1% of demand, although dialysis centers and homecare settings are gaining importance as healthcare delivery becomes more decentralized.

North America held the largest regional share at 39.3% in 2025, while Asia-Pacific is projected to be the fastest-growing region with a 7.5% CAGR. Expanding public dialysis programs, home-based care, early screening, and investments in renal healthcare are expected to support market development through 2035.

Explore additional reports to understand evolving market landscapes:

Reverse Transcriptase Market Outlook

Pulmonary Function Testing Systems (PFT) Market Analysis

Infusion Systems Market Distribution

US Vasomotor Symptoms Market Size

India Contact Lenses Manufacturers Market Share